MTAP and urothelial carcinoma: While other mechanisms such as promoter methylation may contribute to MTAP expression loss in rare cases, our data demonstrate that biallelic genomic loss is the major (and probably only) mechanism that can cause complete MTAP deficiency in urothelial carcinoma.